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Spinal ependymomas are very rare tumors, with ap-
proximately 227 intradural spinal ependymomas diag-
nosed each year in the US. Of the intradural ependymo-
mas, approximately 50% are intramedullary, above the
conus, and the remaining 50% occur in association with
the terminal filum, cauda equina, and conus medullar-
is.3,6,22 In the lumbosacral region, ependymomas account
for 90% of intradural tumors.10 In addition to occurring
intradurally, ependymomas can also sometimes occur ex-
tradurally around or in the sacrum. 
Spinal ependymomas are most common in the fourth
decade of life and are more common in male patients.5,33,37
Sonneland, et al.,32 reported a 1.7:1.0 male/female ratio
and a mean age at onset of 36.4 years (range 6–82 years)
in the largest series (77 patients) of myxopapillary epen-
dymomas reported in the literature. All of the tumors were
intradural in this series, with the majority occurring in the
lumbosacral region.
Bimodal peaks have been suggested for extraspinal ep-
endymomas in the sacral region, with one peak at less than
8 years of age and one in the fourth decade of life.20,21
Others have suggested that extraspinal ependymomas oc-
cur in younger patients compared with intraspinal epen-
dymomas.1,15,17,21,25 There appears to be no significant sex
predominance for extradural ependymomas.15,21,25
OVERVIEW
Tumor Locations and Features
Spinal ependymomas can originate from either the ep-
endymal lining of the central canal of the spinal cord,
ependymal cell clusters in the terminal filum, or from ep-
endymal rests left during embryonic development. Intra-
medullary tumors above the lumbosacral region almost
uniformly arise from the ependymal lining of the spinal
cord. These intradural, intramedullary ependymomas are
predominantly the cellular ependymoma histiotype.6,22
In the lumbosacral region, the majority of ependymo-
mas arise from the intradural terminal filum. These are
characteristically well-encapsulated, sausage-shaped tu-
mors with the nerve roots of the cauda equina draped over
the surface of the lesion or enveloped by it (Fig. 1). Myx-
opapillary ependymomas comprise the majority of epen-
dymomas that arise in this area, but papillary and cellular
histiotypes can also occur here.3–5,9,10,13,22
Extradural ependymomas are very rare and are known
to occur in four perisacral locations, as follows: 1) the
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Abbreviations used in this paper: CNS = central nervous system;
CSF = cerebrospinal fluid; MR = magnetic resonance.
extradural spinal canal in association with the dural part of
the terminal filum; 2) the bone substance of the sacrum; 3)
the pelvic cavity anterior to the sacrum; and 4) the subcu-
taneous tissues dorsal to the sacrum.10,14,17,20,21,30 Because
of the erosive nature of these tumors, it may be impossi-
ble to differentiate between one that starts within the bone
of the sacrum and one that starts in the extradural spinal
canal and erodes into the sacrum. Based on the number of
case reports in the literature, the posterior subcutaneous
location is the most common one for extradural ependy-
momas, followed by the presacral region.10,11,25
Intraspinal extradural sacral ependymomas arise from
ependymal cell remnants in the extradural dural part of the
terminal filum. The other extradural ependymomas likely
arise from ependymal rests that are present at the time of
birth. Bale2 reported finding ependymal rests in the dorsal
sacral subcutaneous tissues in necropsy samples obtained
in 10 of 15 infants. Others have reported finding ependy-
mal rests in tissue obtained during pilonidal cyst resec-
tion.25 One theory is that the ependymal cell rests arise
from the coccygeal medullary vestige, a remnant of the
dural part of the terminal filum that involutes during em-
bryonic development. Others hypothesize that these ep-
endymal rests are heterotopias that occur as a result of
incomplete closure of the neural arch.12,16,17,20 Presacral ep-
endymomas are thought to arise from ependymal cell rests
or in association with cauda equina nerve roots that have
exited the sacral neural foramen. Histologically, all report-
ed cases of extradural ependymomas have been myxopap-
illary types.8,10,16,17,25,34
Tumor Symptoms
Back pain and occasionally radicular pain are the most
common presenting symptoms for intradural ependymo-
mas arising from the terminal filum in the lumbosacral re-
gion. Motor or sensory abnormalities and bladder dys-
function may also develop in association with these le-
sions involving the cauda equina.5,24
Extraspinal ependymomas can present with a variety of
symptoms caused by local mass effect. Intrasacral and in-
traspinal extradural tumors present most commonly with
local pain caused by erosion into the sacrum, but can also
present with radicular or neurological symptoms caused
by neural element compression.2,24 Dorsal subcutaneous
tumors typically present as a growing, asymptomatic mass
in the intergluteal fold or buttocks. Occasionally there can
be pain or tenderness caused by local mass effect, and
very rarely neurological symptoms are reported.1,9,17,21,25
Presacral pelvic masses can grow to be very large, because
of significant tolerance for masses in this area. With suffi-
cient size, presacral masses eventually cause bowel or
bladder dysfunction from local mass effect or neural in-
volvement (Fig. 2).2,10,21 Some patients may have a palpa-
ble mass on rectal examination. Rarely, presacral tumors
cause pain in a sciatic nerve distribution or local pain from
erosion into the sacrum.2,20,21,34
Preoperative Evaluation
All patients with these tumors require a complete neu-
rological examination and MR imaging to delineate local
disease. Intradural ependymomas can disseminate through
CSF pathways throughout the CNS, but are not likely to
metastasize outside it,21 although rare cases of this phe-
nomenon have been reported.27,35 Therefore, we recom-
mend preoperative screening MR imaging of the entire
CNS to rule out tumor dissemination. Screening of other
organ systems for metastases is not needed for intradural
tumors. Preoperative plain anteroposterior and lateral
x-ray films of the lumbosacral spine may also be valuable
for comparison if instability or deformity develop after
laminectomy surgery.23
Extradural tumors, in contrast, are not likely to dissem-
inate within the CNS, but are at significant risk of metas-
tasizing to other organ systems, such as lymph, bone,
lung, and liver. Use of MR or computerized tomography
studies is sufficient to evaluate local disease and we see no
need to screen the entire CNS. In addition, plain x-ray
films or computerized tomography scans may be warrant-
ed in extradural ependymomas to provide further detail
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Fig. 1. Sagital MR image with Gd contrast demonstrating an
intradural ependymoma at the level of the cauda equina.
Fig. 2. Left: Sagittal noncontrast MR image demonstrating a
presacral ependymoma and an enlarged bladder due to urinary re-
tention. Right: Axial noncontrast MR image demonstrating a pre-
sacral ependymoma.
about bone involvement. We recommend paying particu-
lar attention to general examination for lymphadenopathy,
especially in the inguinal lymph nodes,15 and would also
obtain chest x-ray films, liver function tests, and alkaline
phosphatase levels preoperatively. Presacral tumors war-
rant a special workup that likely requires an abdominal/
pelvic surgical specialist. Other studies, such as barium
enema, intravenous pyelogram, cystoscopy, and pelvic ex-
amination may need to be performed for presacral tu-
mors.21
Treatment Options
There are no prospective, randomized studies in which
the management options of surgery alone, surgery fol-
lowed by radiation, radiation alone, or chemotherapy are
examined. 
Surgery Alone. The surgical goal with all ependymo-
mas, whether they are intra- or extradural, is gross-total
resection when feasible.16 Gross-total resection provides a
possibility for cure without the definite need for adjuvant
therapy. For intradural ependymomas in this location,
gross-total resection is the most frequently cited factor
influencing prognosis in terms of local recurrence and
patient survival.5,28,33 Some authors report higher recur-
rence rates for tumors removed in a piecemeal fashion,
even though gross-total resection was achieved.33,35 There-
fore, when possible, en bloc resection is preferred over
piecemeal removal. Other factors, such as duration of clin-
ical symptoms and tumor involvement with conus med-
ullaris or cauda equina, have also been cited (Fig. 3).5
Obviously, when the conus medullaris and cauda equi-
na are involved with the tumor, achieving gross-total re-
section becomes more difficult. In fact, Celli, et al.,5 found
that gross-total resection could be obtained in only 43% of
cases when the conus medullaris or cauda were involved
with the tumor. They also noted that, despite gross-total
resection at the time of surgery, tumors involving the
conus medullaris or cauda equina were more likely to
recur. Sonneland, et al.,33 reported gross-total resection in
59% of a series of 77 patients with predominantly termi-
nal filum/conus medullaris/cauda equina lesions.
For posterior extradural lesions without sacral involve-
ment, wide local excision for gross-total resection is advo-
cated.10,20 Plastic surgery assistance may be needed for
complex skin closure techniques required after resection
of large masses. Some authors have recommended coc-
cygectomy in addition to local excision as a means of re-
ducing the risk of recurrence.15
The surgical approach for presacral lesions depends on
the degree of sacral involvement. Isolated presacral tu-
mors with minimal to no sacral involvement may be radi-
cally resected via just an anterior approach. When the
sacrum is involved, combined anterior–posterior ap-
proaches, either in the same sitting or during different op-
erations, may be needed.10,20
Resection Followed by Radiation. The role of radiation
for lumbosacral ependymomas has not been adequately
studied to warrant firm conclusions. There appears to be a
consensus for radiation therapy in cases of subtotal resec-
tions of intradural tumors, although the role for radiation
in cases of gross-total resection and extradural ependymo-
mas is controversial.3,5,7,10,11,16,28,29,31,33,35
Sonneland, et al.,33 based on their large series of pa-
tients, recommended local radiation therapy in cases of
subtotal or piecemeal gross-total resection. Nevertheless,
in reviewing their data, there appears to be no trend to-
ward improved survival or recurrence rates with radia-
tion therapy. Ross, et al.,28 in a review of the 131 cases in
the literature, concluded that although no differences in
outcome after radiation have been shown for gross-total
and subtotal resection, results in individual cases show
that long-term tumor control can be achieved with this
modality.
Waldron, et al.,35 in a large series of spinal ependymo-
mas, performed multivariate analysis in patients who re-
ceived radiation after surgery. They evaluated the follow-
ing variables: age, sex, preoperative symptom duration,
preoperative functional status, tumor location, and histo-
logical grade. They found that only histological grade was
statistically significant in regard to predicting recurrence-
free survival and cause-specific survival. They reported a
cause-specific actuarial survival at 5 and 10 years of 86
and 81%, respectively. Nevertheless, their results may not
correspond completely with lumbosacral ependymomas
because in their group of 59 patients approximately half of
the tumors were above the level of the conus medullaris.
They note that in patients with well-differentiated tumors,
like those typically found in the lumbosacral region, there
was a 97% 5-year, cause-specific survival. Although these
survival rates with radiation appear to be excellent, when
we compare these figures with overall survival rates for
lumbosacral ependymomas there appears to be no signifi-
cant difference. Waldron, et al.,35 reported no cases of ra-
diation myelopathy in the 59 spinal ependymomas treated,
and others report very low complication rates with spinal
irradiation in this area.31 Therefore, although they are not
scientifically proven, the potential benefits of radiation
therapy appear to outweigh the risks and can be justified
in cases of subtotal tumor resection. 
Radiation Therapy After Biopsy Sampling. Waldron, et
al.,35 report on five patients who received radiation thera-
py after biopsy sampling in which a diagnosis of ependy-
moma was made. This subgroup was included in a larger
series of 59 patients who received radiation after surgery
(biopsy or resection), and it is difficult to discern from the
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Fig. 3. Intraoperative photograph of an intradural ependymoma
in the lumbar thecal sac.
authors’ data the tumor location, histological findings, and
results in these five patients. Waldron, et al., report that
three of these five patients were alive at the last follow-
up review. Others have used radiation therapy alone after
biopsy procedures for lumbosacral ependymomas, with
apparently very good long-term results, although the num-
ber of cases in each series is small.32,36
Radiation Therapy for Recurrence or Metastases. For
intradural ependymomas, radiation therapy is often used
in cases of local recurrence and disseminated disease
within the CNS. Intradural myxopapillary ependymomas
have been shown to be radiosensitive, and long-term tu-
mor control can be achieved with this adjunctive therapy
in most cases of local recurrence or CNS metastases.7,28
Extradural ependymomas have not shown as promising
results as intradural tumors. These extradural tumors are
rare; therefore, sufficient data are lacking to draw conclu-
sions on the effectiveness of radiotherapy. Most cases of
local recurrence are treated with surgery and not radiation.
With the limited data available, prolonged survival has not
been observed in patients who receive radiotherapy for
extradural ependymomas. Metastatic disease to other or-
gan systems typically does not respond to radiation thera-
py or chemotherapy.15
Chemotherapy. This modality has been restricted pri-
marily to patients with recurrent disease that has been re-
fractory to resection and radiation. A number of che-
motherapeutic agents have been tried in small series of
recurrent spinal ependymomas, but no studies have shown
compelling evidence to indicate that chemotherapy may
be a primary treatment for these tumors.6,10,33,34 Individual
case reports18 describe control of myxopapillary epen-
dymoma with chemotherapy, but sufficient data are lack-
ing to draw any significant conclusions regarding this
regimen.
Prognosis for Ependymomas. Most ependymomas oc-
curring in the lumbosacral region are myxopapillary on
histological examination. Even though intraspinal myx-
opapillary ependymomas are considered benign, they
are known to recur locally and can disseminate through
CSF pathways. Even with gross-total resection, recur-
rence rates of 4 to 29% have been reported.3–5 Although
described by Davis and Barnard9 in 1985, the potential for
dissemination of these lesions throughout the CNS has
only recently been truly appreciated.26,27,38 Disseminated
disease can arise many years after initial tumor present-
ation.9,26
Despite the significant risk of local recurrence and
CSF dissemination, the overall prognosis for lumbosacral
intradural myxopapillary ependymomas appears to be
very good. Sonneland, et al.,33 reported long-term survival
in approximately 95% of patients in their series of 77
patients. Mork and Loken,22 in another large series of
spinal ependymomas, reported a 10-year survival rate of
94% for patients with lumbosacral intradural ependymo-
mas and noted that the myxopapillary histiotype had a
favorable prognosis. The few patients who die as a result
of primary disease typically do so after a prolonged course
with multiple recurrences. 
Extradural ependymomas are a different entity com-
pared with intradural tumors because of the risk of local
recurrence and distal metastasis. For presacral tumors, lo-
cal recurrence has been reported to be as high as 60%,
with mortality rates as high as 75% over a period of 4
years for cases of recurrence.20,34 Local recurrence for
dorsal subcutaneous tumors is approximately 25% at 15
years.10 Overall, extradural lesions are much more likely
to metastasize to other organ systems than intradural
tumors, with the lymphatic system, lungs, bones, and liver
being the most common sites.9 The tendency for extradur-
al tumors to metastasize is likely because of the closer
proximity of lymphatic and vascular channels in extradur-
al locations. The risk of metastases also depends on the
specific extradural location, with dorsal subcutaneous tu-
mors at greater risk for metastasis than presacral tumors.
Intrasacral lesions have also been reported to metastasize,
but this appears to be very rare.19,27 Metastases have been
reported in up to 20% of dorsal subcutaneous tumors in
long-term follow up.14 Metastatic disease from extradural
ependymomas appears to carry a grim prognosis due to
lack of response to adjuvant therapies.  
CONCLUSIONS
Lumbosacral ependymomas consist of two distinct enti-
ties that must be managed differently. The more common
intradural ependymoma has a significant risk of both local
recurrence and dissemination to other areas of the CNS.
The rare extradural sacral region ependymoma has the
potential for extraneural metastases in addition to local
recurrence. The possibility of metastases for lesions in
both of these locations should be taken into account in
preoperative evaluation and in long-term follow up. 
In both tumor locations, gross-total resection is the
treatment of choice when feasible. Radiation therapy may
be valuable for subtotal intradural resections or CNS me-
tastases from intradural tumors. Radiotherapy for extra-
dural lesions does not appear to be as effective and is more
controversial. 
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